Marine polysaccharide-based medicine for treating osteoporosis

A technology of osteoporosis and marine polysaccharides, applied in the field of medicine, can solve the problems of treating the symptoms but not the root cause, failure to fundamentally improve osteoarthritis and lesions, and large side effects

Inactive Publication Date: 2018-03-23
DALIAN SHENLAN PEPTIDE TECH R & D CO LTD
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are two major categories of drugs currently used to treat and prevent the development of osteoporosis. The first category is drugs that inhibit bone resorption, including calcium, vitamin D, calcitonin, bisphosphonates, estrogen and isoflavones; Drugs for promoting bone formation, including fluoride, synthetic steroids, parathyroid hormone, and isoflavones. Alth

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1: A drug for treating osteoporosis based on marine polysaccharides, which consists of the following raw materials in parts by weight: 10 parts of sea cucumber glycopeptides, 8 parts of seaweed polysaccharides, 1.8 g of glucosamine, 6 parts of fish collagen peptides, and Eucommia ulmoides extract 5 parts, 4 parts of Epimedium extract, 8 parts of Caulis Spatholobus extract, 3 parts of Rehmannia glutinosa extract, 7 parts of Lycium barbarum extract.

Embodiment 2

[0020] Embodiment 2 case:

[0021] (1) Chen Moumou, male, 60 years old. Lumbar pain, knee joint pain, fear of cold, inconvenient walking, prone to habitual ankle fractures, taking calcium supplements is ineffective, and multi-treatment does not improve. After taking this prescription for half a year, the symptoms disappeared without any physical discomfort.

[0022] (2) Jiang Moumou, female, 65 years old, has weak constitution, general weakness, shortness of breath, pain in the cervical spine, sore waist, stooped back, and many treatments are ineffective. After taking this prescription for one month, the above symptoms are obviously relieved, continue to take it Eight months later, my body returned to normal. Although my back is still hunchbacked, I have no body pain, increased physical strength, and no inconvenience in life.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicine for treating osteoporosis based on marine polysaccharides, which is composed of the following raw materials in parts by weight: 8-10 parts of sea cucumber glycopeptide, 6-8 parts of seaweed polysaccharide, 1.5-2.0 g of glucosamine, fish collagen 6-8 parts of protein peptide, 4-5 parts of Eucommia extract, 3-4 parts of Epimedium extract, 6-8 parts of Caulis Spatholobus extract, 3-4 parts of Rehmannia glutinosa extract, 5-7 parts of Lycium barbarum extract , this formula can eliminate joint inflammation, relieve pain, repair damaged articular cartilage and promote regeneration, and improve immunity by supplementing collagen, polypeptide, polysaccharide, calcium and other nutrients needed by bone joints. TCM theory promotes blood circulation and collaterals, nourishes liver and kidney, strengthens tendons and bones, and together achieves the fundamental purpose of treating osteoporosis.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to a medicine for treating osteoporosis. Background technique [0002] Osteoporosis is a bone and joint disease caused by a variety of reasons. The symptoms are mostly bone pain, limited mobility, shortened body length, hunchback, and easy fractures. Divided into primary and secondary osteoporosis, mostly senile osteoporosis and postmenopausal osteoporosis are the most common, and the elderly and women are the most common groups. With the aggravation of social aging, people suffering from osteoporosis population is also on the rise. [0003] There are two major categories of drugs currently used to treat and prevent the development of osteoporosis. The first category is drugs that inhibit bone resorption, including calcium, vitamin D, calcitonin, bisphosphonates, estrogen and isoflavones; Drugs for promoting bone formation, including fluoride, synthetic steroids, parathyroid hormone, and i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/39A61P19/10A61K31/7008A61K31/715A61K38/14A61K36/815
CPCA61K36/46A61K31/7008A61K31/715A61K36/296A61K36/486A61K36/804A61K36/815A61K38/14A61K38/39A61K2300/00
Inventor 包卫洋左爱华杨大苹王祖哲
Owner DALIAN SHENLAN PEPTIDE TECH R & D CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap